Literature DB >> 16410923

Cytokine serum levels in patients infected by human immunodeficiency virus with and without Trypanosoma cruzi coinfection.

Denise Bertulucci Rocha Rodrigues1, Dalmo Correia, Mônica Dias Marra, Luis Eduardo Ramirez Giraldo, Eliane Lages-Silva, Mario León Silva-Vergara, Cristina Hueb Barata, Virmondes Rodrigues Junior.   

Abstract

This study assessed the number of CD4 T lymphocytes, the parasitemia and serum levels of interferon gamma (IFN-gamma), tumor necrosis factor alpha (TNF-alpha), interleukin-1 (IL-1), IL-4 and IL-10 of patients infected by human immunodeficiency virus (HIV) and human immunodeficiency virus/Chagas' disease coinfection. CD4 T lymphocytes were low in the two groups of patients, although significantly lower in patients without Chagas' disease. Serum levels of IFN-gamma, IL-4 and TNF-alpha were significantly higher in patients with HIV/Chagas' disease. IL-4/IFN-gamma ratios were higher in patients with HIV/Chagas' disease, which showed a clear balance in favor of Th2-like cytokines in this group of patients. This Th2 balance was higher in patients with detectable parasitemia. We conclude that, although immunosuppression was observed, with CD4 T lymphocytes below 200/microm3, these patients did not display reactivation of T. cruzi infection and that a balance favorable to Th2 was associated with the presence of parasitemia.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16410923     DOI: 10.1590/s0037-86822005000600007

Source DB:  PubMed          Journal:  Rev Soc Bras Med Trop        ISSN: 0037-8682            Impact factor:   1.581


  6 in total

Review 1.  Chronic Chagas' heart disease: a disease on its way to becoming a worldwide health problem: epidemiology, etiopathology, treatment, pathogenesis and laboratory medicine.

Authors:  Silvia Gilka Muñoz-Saravia; Annekathrin Haberland; Gerd Wallukat; Ingolf Schimke
Journal:  Heart Fail Rev       Date:  2012-01       Impact factor: 4.214

2.  Study on the blood-borne virus co-infection and T lymphocyte subset among intravenous drug users.

Authors:  Jian-Rong Li; Rui-Yu Gong; Kun-Lun Tian; Jing Wang; Yi-Xin Wang; Han-Ju Huang
Journal:  World J Gastroenterol       Date:  2007-04-28       Impact factor: 5.742

3.  Role of T. cruzi exposure in the pattern of T cell cytokines among chronically infected HIV and Chagas disease patients.

Authors:  Tania Regina Tozetto-Mendoza; Dewton de Moraes Vasconcelos; Karim Yaqub Ibrahim; Ana Marli Christovam Sartori; Rita C Bezerra; Vera Lúcia Teixeira de Freitas; Maria Aparecida Shikanai-Yasuda
Journal:  Clinics (Sao Paulo)       Date:  2017-11       Impact factor: 2.365

4.  Clinical profile and mortality in patients with T. cruzi/HIV co-infection from the multicenter data base of the "Network for healthcare and study of Trypanosoma cruzi/HIV co-infection and other immunosuppression conditions".

Authors:  Maria Aparecida Shikanai-Yasuda; Mauro Felippe Felix Mediano; Christina Terra Gallafrio Novaes; Andréa Silvestre de Sousa; Ana Marli Christovam Sartori; Rodrigo Carvalho Santana; Dalmo Correia; Cleudson Nery de Castro; Marilia Maria Dos Santos Severo; Alejandro Marcel Hasslocher-Moreno; Marisa Liliana Fernandez; Fernando Salvador; Maria Jesús Pinazo; Valdes Roberto Bolella; Pedro Carvalho Furtado; Marcelo Corti; Ana Yecê Neves Pinto; Alberto Fica; Israel Molina; Joaquim Gascon; Pedro Albajar Viñas; Juan Cortez-Escalante; Alberto Novaes Ramos; Eros Antonio de Almeida
Journal:  PLoS Negl Trop Dis       Date:  2021-09-30

Review 5.  Acute chagas disease: new global challenges for an old neglected disease.

Authors:  Daniela V Andrade; Kenneth J Gollob; Walderez O Dutra
Journal:  PLoS Negl Trop Dis       Date:  2014-07-31

6.  A Specific IL6 Polymorphic Genotype Modulates the Risk of Trypanosoma cruzi Parasitemia While IL18, IL17A, and IL1B Variant Profiles and HIV Infection Protect Against Cardiomyopathy in Chagas Disease.

Authors:  Alexandra Gomes Dos Santos; Elieser Hitoshi Watanabe; Daiane Tomomi Ferreira; Jamille Oliveira; Érika Shimoda Nakanishi; Claudia Silva Oliveira; Edimar Bocchi; Cristina Terra Gallafrio Novaes; Fatima Cruz; Noemia Barbosa Carvalho; Paula Keiko Sato; Edite Hatsumi Yamashiro-Kanashiro; Alessandra Pontillo; Vera Lucia Teixeira de Freitas; Luiz Fernando Onuchic; Maria Aparecida Shikanai-Yasuda
Journal:  Front Immunol       Date:  2020-10-22       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.